ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.
Follow-Up Questions
Asep Medical Holdings Inc의 CEO는 누구입니까?
Dr. Robert Hancock은 2021부터 회사에 합류한 Asep Medical Holdings Inc의 Chief Executive Officer입니다.
SEPSF 주식의 가격 성능은 어떻습니까?
SEPSF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Asep Medical Holdings Inc의 주요 사업 주제나 업종은 무엇입니까?
Asep Medical Holdings Inc은 N/A 업종에 속하며, 해당 부문은 N/A입니다
